Table 1.

Patient characteristics of 106 adult Gaucher type 1 patients




AMC

HHU

P
No. of patients   49   57   NA  
Age in 2003, y, median (range)   47.0 (21-74)   49.0 (21-82)   NS  
Men, no. (%)   27 (55%)   25 (43%)   NS  
Splenectomies, no. (%)   19 (39%)   19 (33%)   NS  
SSI, median (range)   8 (3-18)   7.0 (2-16)   NS  
Hb, g/dL, median (range)   12.0 (8.0-15.8)   12.6 (7.7-16.5)   .028  
Platelet count × 109/L, median (range)   93 (17-726)   73 (9-463)   NS  
Liver volume, mL, median (range)   3095 (1504-6542)   1741 (1048-2821)   < .001  
Spleen volume, mL, median (range)   1400 (470-4821)   1597 (365-4195)   NS  
BMB score, median (range)   6.5 (0-8)   7 (3-8)   NS  
Chitotriosidase, nmol/mL/h, median (range)   16 703 (5316-102 324)   11 869 (592-39 791)   .056  
Patients with a serious bone complication in the 10 y prior to start of ERT, no. (%)   21 (43)   25 (44)   NS  
Start dose, U/kg/4 wk, median (range)   15 (15-50)   80 (60-120)   < .001  
ERT cost per y for a 70-kg (154-lb) patient at start dose, median, US $ (€)
 
69.85 (55.165)
 
376.44 (294.221)
 
NA
 



AMC

HHU

P
No. of patients   49   57   NA  
Age in 2003, y, median (range)   47.0 (21-74)   49.0 (21-82)   NS  
Men, no. (%)   27 (55%)   25 (43%)   NS  
Splenectomies, no. (%)   19 (39%)   19 (33%)   NS  
SSI, median (range)   8 (3-18)   7.0 (2-16)   NS  
Hb, g/dL, median (range)   12.0 (8.0-15.8)   12.6 (7.7-16.5)   .028  
Platelet count × 109/L, median (range)   93 (17-726)   73 (9-463)   NS  
Liver volume, mL, median (range)   3095 (1504-6542)   1741 (1048-2821)   < .001  
Spleen volume, mL, median (range)   1400 (470-4821)   1597 (365-4195)   NS  
BMB score, median (range)   6.5 (0-8)   7 (3-8)   NS  
Chitotriosidase, nmol/mL/h, median (range)   16 703 (5316-102 324)   11 869 (592-39 791)   .056  
Patients with a serious bone complication in the 10 y prior to start of ERT, no. (%)   21 (43)   25 (44)   NS  
Start dose, U/kg/4 wk, median (range)   15 (15-50)   80 (60-120)   < .001  
ERT cost per y for a 70-kg (154-lb) patient at start dose, median, US $ (€)
 
69.85 (55.165)
 
376.44 (294.221)
 
NA
 

NA indicates not applicable; NS, not significant.

or Create an Account

Close Modal
Close Modal